“We spent last few years building most efficient Digital Healthcare Platform in terms of Cost, Consumer Experience and Capital. The continued focus
SastaSundar Ventures – A new player in the e-pharmacy space

“We spent last few years building most efficient Digital Healthcare Platform in terms of Cost, Consumer Experience and Capital. The continued focus
“At a time when the world is realizing the importance of prevention more than ever before, it is a matter of pride
Vijaya Diagnostic Centre Limited (NSE:VIJAYA) Q2 FY23 Earnings Concall dated Nov. 11, 2022 Corporate Participants: Suprita Reddy -- Chief Executive Officer Narasimha
Metropolis Healthcare Limited (NSE:METROPOLIS) Q2 FY23 Earnings Concall dated Nov. 08, 2022 Corporate Participants: Ameera Shah -- Managing Director Rakesh Agarwal --
Key highlights from Sun Pharmaceutical Industries Limited (SUNPHARMA) Q2 FY23 Earnings Concall Q&A Highlights: [00:16:46] Tushar Manudhane of Motilal Oswal asked about
Dr Lal PathLabs Ltd (NSE:LALPATHLAB) Q1 FY23 Earnings Concall dated Jul. 28, 2022 Corporate Participants: Arvind Lal -- Executive Chairman Om Prakash
Overview Dr Lal PathLabs Limited is an Indian diagnostic company. It was incorporated in 1949. The headquarters is situated in Delhi, India. It
Dr Lal PathLabs Ltd (NSE: LALPATHLAB) Q4 FY22 Earnings Concall dated May. 17, 2022 Corporate Participants: Nishid Solanki -- Arvind Lal -- Executive Chairman Om
Diagnostic services have become the cornerstone of healthcare, especially for recommending treatments and monitoring post-treatment recovery. The diagnostics industry in India, valued